From Young to Old: Mimicking Neuronal Aging in Directly Converted Neurons from Young Donors.
cortisol
directly converted neurons from human fibroblasts
mitochondria
rotenone
stress
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
26 Jul 2024
26 Jul 2024
Historique:
received:
27
06
2024
revised:
23
07
2024
accepted:
24
07
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
9
8
2024
Statut:
epublish
Résumé
A substantial challenge in human brain aging is to find a suitable model to mimic neuronal aging in vitro as accurately as possible. Using directly converted neurons (iNs) from human fibroblasts is considered a promising tool in human aging since it retains the aging-associated mitochondrial donor signature. Still, using iNs from aged donors can pose certain restrictions due to their lower reprogramming and conversion efficacy than those from younger individuals. To overcome these limitations, our study aimed to establish an in vitro neuronal aging model mirroring features of in vivo aging by acute exposure on young iNs to either human stress hormone cortisol or the mitochondrial stressor rotenone, considering stress as a trigger of in vivo aging. The impact of rotenone was evident in mitochondrial bioenergetic properties by showing aging-associated deficits in mitochondrial respiration, cellular ATP, and MMP and a rise in glycolysis, mitochondrial superoxide, and mitochondrial ROS; meanwhile, cortisol only partially induced an aging-associated mitochondrial dysfunction. To replicate the in vivo aging-associated mitochondrial dysfunctions, using rotenone, a mitochondrial complex I inhibitor, proved to be superior to the cortisol model. This work is the first to use stress on young iNs to recreate aging-related mitochondrial impairments.
Identifiants
pubmed: 39120291
pii: cells13151260
doi: 10.3390/cells13151260
pii:
doi:
Substances chimiques
Rotenone
03L9OT429T
Hydrocortisone
WI4X0X7BPJ
Reactive Oxygen Species
0
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Swiss National Science Foundation
ID : 31003A-179294
Pays : Switzerland
Organisme : Novartis Foundation
ID : 18C143
Organisme : European Union's Seventh Framework Programme
ID : FP7/2007-2013
Organisme : Innovative Medicines Initiative Joint Undertaking
ID : 115439
Organisme : EFPIA companies